IART Q1 2023 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$381M+1.1% YoY

Gross Profit

$233M61.1% margin

Operating Income

$36M9.6% margin

Net Income

$24M6.4% margin

EPS (Diluted)

$0.29

QoQ Revenue Growth

-4.3%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$2.1B

Stockholders' Equity

$1.7B

Cash & Equivalents

$307M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$381M	$377M	+1.1%
Gross Profit	$233M	$234M	-0.5%
Operating Income	$36M	$46M	-21.2%
Net Income	$24M	$33M	-26.4%

Revenue Segments

Codman Specialty Surgical

$248M65%

Tissue Technologies

$133M35%

Geographic Segments

UNITED STATES

$271M71%

Asia Pacific

$50M13%

Europe

$41M11%

Rest Of World

$18M5%